Healthcare professionals / Gastroenterology / HabibTM EndoHPB Bipolar Radiofrequency Catheter / Pancreatic Cancer Stricture Management

Pancreatic Cancer Stricture Management

Clinical Challenge

  • Mean survival is 6-121,2 months for the 80% of pts who are non-surgical candidates.
  • Mean stent patency (metal): 72d3.
  • Therefore, more than half of the patients may outlive the patency of their stents.
  • Malignant biliary obstruction and cholangitis are the most commonly seen complication in patients suffering from pancreas tumors3.

Clinical Goal for RFA

Provide and maintain biliary decompression and drainage

Literature Highlights

Data is for Ablation + stenting vs stenting alone is mixed, depending upon the study.

  • Mean SEMS Patency Improvement: 97.7%, 143+109 vs 72.3+37, p=0.013
  • Mean SEMS Patency 472d vs 374, p=0.6694 (statistically equivalent)
Disclaimer: Results from different clinical investigations are not directly comparable. Information provided for educational purposes only.
  1. Sharaiha, R et al, Comparison of Metal Stenting with Radiofrequency Ablation Versus Stenting Alone for Treating Malignant Biliary Strictures: Is There an Added Benefit?, Dig Dis Sci, June 2014
  3. Kadayifci, Radiofrequency ablation for the management of occluded biliary metal stents, Endoscopy, 2016
  4. Kallis et al., Analysis of Endoscopic RFA of Biliary Malignant Stricture in Pancreatic Cancer Suggest Potential Survival Benefit, Digestive Diseases, 2015

All trademarks are the property of their respective owners.
CAUTION: The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings and instructions for use can be found in the product labelling supplied with each device.
Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries. This material not intended for use in France.
Product available in the European Economic Area (EEA) only. Please check availability with your local sales representative or customer service.